84
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Cell membrane-cloaked bioinspired nanoparticles: a novel strategy for breast cancer therapy

ORCID Icon, , &
Pages 1351-1363 | Received 17 Nov 2022, Accepted 29 Apr 2023, Published online: 21 May 2023

References

  • Yao, H.; He, G.; Yan, S.; Chen, C.; Song, L.; Rosol, T. J.; Deng, X. Triple-Negative Breast Cancer: Is There a Treatment on the Horizon? Oncotarget. 2017, 8, 1913–1924. DOI: 10.18632/oncotarget.12284.
  • Barrios, C. H. Global Challenges in Breast Cancer Detection and Treatment. Breast. 2022, 62, S3–S6. DOI: 10.1016/j.breast.2022.02.003.
  • Global Cancer Observatory. https://gco.iarc.fr/today/online-analysis-multi-bars?v=2020&mode=cancer&mode_population=countries&population=900&populations=900&key=crude_rate&sex=2&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=10&group_cancer=1&include_nmsc=0&include_nmsc_other=1&type_multiple=%257B%2522inc%2522%253Afalse%252C%2522mort%2522%253Atrue%252C%2522prev%2522%253Afalse%257D&orientation=horizontal&type_sort=0&type_nb_items=%257B%2522top%2522%253Atrue%252C%2522bottom%2522%253Afalse%257D. (accessed Mar 30, 2023).
  • O'Conor, C. J.; Chen, T.; González, I.; Cao, D.; Peng, Y. Cancer Stem Cells in Triple-Negative Breast Cancer: A Potential Target and Prognostic Marker. Biomark. Med. 2018, 12, 813–820. DOI: 10.2217/bmm-2017-0398.
  • Napier, M. E.; DeSimone, J. M. Nanoparticle Drug Delivery Platform. Polymer Revs. 2007, 47, 321–327. DOI: 10.1080/15583720701454999.
  • Khan, D. R.; Webb, M. N.; Cadotte, T. H.; Gavette, M. N. Use of Targeted Liposome-Based Chemotherapeutics to Treat Breast Cancer. Breast Cancer (Auckl). 2015, 9, 1–5. DOI: 10.4137/BCBCR.S29421.
  • Alqaraghuli, H. G. J.; Kashanian, S.; Rafipour, R. A Review on Targeting Nanoparticles for Breast Cancer. Curr. Pharm. Biotechnol. 2019, 20, 1087–1107. DOI: 10.2174/1389201020666190731130001.
  • Tajabadi, M. Application of Carbon Nanotubes in Breast Cancer Therapy. Drug Res. (Stuttg). 2019, DOI: 10.1055/a-0945-1469.
  • Oprita, A.; Sevastre, A.-S. New Pharmaceutical Dosage Forms Used in the Treatment of Breast Cancer. Polymeric Micelles. MONC. 2020, 1, 38–52. DOI: 10.52701/monc.2020.v1i1.9.
  • Anajafi, T.; Mallik, S. Polymersome-Based Drug-Delivery Strategies for Cancer Therapeutics. Ther. Deliv. 2015, 6, 521–534. DOI: 10.4155/tde.14.125.
  • Paliwal, R.; Paliwal, S. R.; Kenwat, R.; Kurmi, B. D.; Sahu, M. K. Solid Lipid Nanoparticles: A Review on Recent Perspectives and Patents. Expert Opin. Ther. Pat. 2020, 30, 179–194. DOI: 10.1080/13543776.2020.1720649.
  • Alven, S.; Aderibigbe, B. A. The Therapeutic Efficacy of Dendrimer and Micelle Formulations for Breast Cancer Treatment. Pharmaceutics. 2020, 12, 1212. DOI: 10.3390/pharmaceutics12121212.
  • Abbas, Z. S.; Sulaiman, G. M.; Jabir, M. S.; Mohammed, S. A.; Khan, R. A.; Mohammed, H. A.; Al-Subaiyel, A. Galangin/β-Cyclodextrin Inclusion Complex as a Drug-Delivery System for Improved Solubility and Biocompatibility in Breast Cancer Treatment. Molecules. 2022, 27, 4521. DOI: 10.3390/molecules27144521.
  • Yih, T.; Al‐Fandi, M. Engineered Nanoparticles as Precise Drug Delivery Systems. J. Cell. Biochem. 2006, 97, 1184–1190. DOI: 10.1002/jcb.20796.
  • Suk, J. S.; Xu, Q.; Kim, N.; Hanes, J.; Ensign, L. M. PEGylation as a Strategy for Improving Nanoparticle-Based Drug and Gene Delivery. Adv. Drug Deliv. Rev. 2016, 99, 28–51. DOI: 10.1016/j.addr.2015.09.012.
  • Sebak, A. A. Limitations of PEGylated Nanocarriers: Unfavourable Physicochemical Properties, Biodistribution Patterns and Cellular and Subcellular Fates. Int. J. App. Pharm. 2018, 10, 6–12. DOI: 10.22159/ijap.2018v10i5.27568.
  • Fang, R. H.; Kroll, A. V.; Gao, W.; Zhang, L. Cell Membrane Coating Nanotechnology. Adv. Mater. 2018, 30, 1706759. DOI: 10.1002/adma.201706759.
  • Zhen, X.; Cheng, P.; Pu, K. Recent Advances in Cell Membrane–Camouflaged Nanoparticles for Cancer Phototherapy. Small. 2019, 15, 1804105. DOI: 10.1002/smll.201804105.
  • Guido, C.; Maiorano, G.; Cortese, B.; D’Amone, S.; Palamà, I. E. Biomimetic Nanocarriers for Cancer Target Therapy. Bioeng. 2020, 7, 111. DOI: 10.3390/bioengineering7030111.
  • Lei, F.; Li, P.; Chen, T.; Wang, Q.; Wang, C.; Liu, Y.; Deng, Y.; Zhang, Z.; Xu, M.; Tian, J.; et al. Recent Advances in Curcumin-Loaded Biomimetic Nanomedicines for Targeted Therapies. J. Drug Deliv. Sci. Technol. 2023, 80, 104200. DOI: 10.1016/j.jddst.2023.104200.
  • Al-Hetty, H. R. A. K.; Kadhim, M. S.; Al-Tamimi, J. H. Z.; Ahmed, N. M.; Jalil, A. T.; Saleh, M. M.; Kandeel, M.; Abbas, R. H. Implications of Biomimetic Nanocarriers in Targeted Drug Delivery. Emergent Mater. 2023, 6, 1–13. DOI: 10.1007/s42247-023-00453-8.
  • Ojha, A.; Jaiswal, S.; Bharti, P.; Mishra, S. K. Nanoparticles and Nanomaterials-Based Recent Approaches in Upgraded Targeting and Management of Cancer: A Review. Cancers. 2023, 15, 162. DOI: 10.3390/cancers15010162.
  • Narain, A.; Asawa, S.; Chhabria, V.; Patil-Sen, Y. Cell Membrane Coated Nanoparticles: Next-Generation Therapeutics. Nanomed. (Lond). 2017, 12, 2677–2692. DOI: 10.2217/nnm-2017-0225.
  • Sosale, N. G.; Spinler, K. R.; Alvey, C.; Discher, D. E. Macrophage Engulfment of a Cell or Nanoparticle is Regulated by Unavoidable Opsonization, a Species-Specific ‘Marker of Self’CD47, and Target Physical Properties. Curr. Opin. Immunol. 2015, 35, 107–112. DOI: 10.1016/j.coi.2015.06.013.
  • Rossi, L.; Fraternale, A.; Bianchi, M.; Magnani, M. Red Blood Cell Membrane Processing for Biomedical Applications. Front. Physiol. 2019, 10, 1070. DOI: 10.3389/fphys.2019.01070.
  • Xuan, M.; Shao, J.; Dai, L.; Li, J.; He, Q. Macrophage Cell Membrane Camouflaged Au Nanoshells for in Vivo Prolonged Circulation Life and Enhanced Cancer Photothermal Therapy. ACS Appl. Mater. Interfaces. 2016, 8, 9610–9618. DOI: 10.1021/acsami.6b00853.
  • Krishnamurthy, S.; Gnanasammandhan, M.; Xie, C.; Huang, K.; Cui, M.; Chan, J. Monocyte Cell Membrane-Derived Nanoghosts for Targeted Cancer Therapy. Nanoscale. 2016, 8, 6981–6985. DOI: 10.1039/C5NR07588B.
  • Sprague, D. L.; Elzey, B. D.; Crist, S. A.; Waldschmidt, T. J.; Jensen, R. J.; Ratliff, T. L. Platelet-Mediated Modulation of Adaptive Immunity: Unique Delivery of CD154 Signal by Platelet-Derived Membrane Vesicles. Blood. 2008, 111, 5028–5036. DOI: 10.1182/blood-2007-06-097410.
  • Sun, H.; Su, J.; Meng, Q.; Yin, Q.; Chen, L.; Gu, W.; Zhang, P.; Zhang, Z.; Yu, H.; Wang, S.; Li, Y. Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors. Adv. Mater. 2016, 28, 9581–9588. DOI: 10.1002/adma.201602173.
  • Osta, W. A.; Chen, Y.; Mikhitarian, K.; Mitas, M.; Salem, M.; Hannun, Y. A.; Cole, D. J.; Gillanders, W. E. EpCAM is Overexpressed in Breast Cancer and is a Potential Target for Breast Cancer Gene Therapy. Cancer Res. 2004, 64, 5818–5824. DOI: 10.1158/0008-5472.CAN-04-0754.
  • Kong, Y.; Lyu, N.; Wu, J.; Tang, H.; Xie, X.; Yang, L.; Li, X.; Wei, W.; Xie, X. Breast Cancer Stem Cell Markers CD44 and ALDH1A1 in Serum: Distribution and Prognostic Value in Patients with Primary Breast Cancer. J. Cancer. 2018, 9, 3728–3735. DOI: 10.7150/jca.28032.
  • Wang, M.; Xin, Y.; Cao, H.; Li, W.; Hua, Y.; Webster, T. J.; Zhang, C.; Tang, W.; Liu, Z. Recent Advances in Mesenchymal Stem Cell Membrane-Coated Nanoparticles for Enhanced Drug Delivery. Biomater. Sci. 2021, 9, 1088–1103. DOI: 10.1039/D0BM01164A.
  • Mohandas, N.; Gallagher, P. G. Red Cell Membrane: Past, Present, and Future. Blood. 2008, 112, 3939–3948. DOI: 10.1182/blood-2008-07-161166.
  • Hu, C.-M. J.; Zhang, L.; Aryal, S.; Cheung, C.; Fang, R. H.; Zhang, L. Erythrocyte Membrane-Camouflaged Polymeric Nanoparticles as a Biomimetic Delivery Platform. Proc. Natl. Acad. Sci. USA. 2011, 108, 10980–10985. DOI: 10.1073/pnas.1106634108.
  • Malhotra, S.; Dumoga, S.; Singh, N. Red Blood Cells Membrane‐Derived Nanoparticles: Applications and Key Challenges in Their Clinical Translation. Wiley Interdiscip. Rev. Nanomed. Nanobiotech. 2022, 14, e1776. DOI: 10.1002/wnan.1776.
  • Lee, N.-H.; You, S.; Taghizadeh, A.; Taghizadeh, M.; Kim, H. S. Cell Membrane-Cloaked Nanotherapeutics for Targeted Drug Delivery. IJMS. 2022, 23, 2223. DOI: 10.3390/ijms23042223.
  • Sabir, F.; Farooq, R. K.; Ahmed.; N.; Asim Ur Rehman. Monocyte as an Emerging Tool for Targeted Drug Delivery: A Review. Curr. Pharm. Des. 2018, 24, 5296–5312. DOI: 10.2174/1381612825666190102104642.
  • Lameijer, M. A.; Tang, J.; Nahrendorf, M.; Beelen, R. H.; Mulder, W. J. Monocytes and Macrophages as Nanomedicinal Targets for Improved Diagnosis and Treatment of Disease. Expert Rev. Mol. Diagn. 2013, 13, 567–580. DOI: 10.1586/14737159.2013.819216.
  • Harris, J. C.; Scully, M. A.; Day, E. S. Cancer Cell Membrane-Coated Nanoparticles for Cancer Management. Cancers. 2019, 11, 1836. DOI: 10.3390/cancers11121836.
  • Jin, J.; Bhujwalla, Z. M. Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their Applications in Cancer Theranostics. Front. Oncol. 2020, 9, 1560. DOI: 10.3389/fonc.2019.01560.
  • Sanghi, R.; Verma, P. Biomimetic Synthesis and Characterisation of Protein Capped Silver Nanoparticles. Bioresour. Technol. 2009, 100, 501–504. DOI: 10.1016/j.biortech.2008.05.048.
  • Minguell, J. J.; Erices, A.; Conget, P. Mesenchymal Stem Cells. Exp. Biol. Med. (Maywood). 2001, 226, 507–520. DOI: 10.1177/153537020122600603.
  • Mohammadi, M.; Jaafari, M.; Mirzaei, H.; Mirzaei, H. Mesenchymal Stem Cell: A New Horizon in Cancer Gene Therapy. Cancer Gene Ther. 2016, 23, 285–286. DOI: 10.1038/cgt.2016.35.
  • Gujrati, V.; Kim, S.; Kim, S.-H.; Min, J. J.; Choy, H. E.; Kim, S. C.; Jon, S. Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer Therapy. ACS Nano. 2014, 8, 1525–1537. DOI: 10.1021/nn405724x.
  • Naskar, A.; Cho, H.; Lee, S.; Kim, K-s Biomimetic Nanoparticles Coated with Bacterial Outer Membrane Vesicles as a New-Generation Platform for Biomedical Applications. Pharmaceutics. 2021, 13, 1887. DOI: 10.3390/pharmaceutics13111887.
  • Zou, S.; Wang, B.; Wang, C.; Wang, Q.; Zhang, L. Cell Membrane-Coated Nanoparticles: Research Advances. Nanomed. (Lond). 2020, 15, 625–641. DOI: 10.2217/nnm-2019-0388.
  • Gong, C.; Yu, X.; You, B.; Wu, Y.; Wang, R.; Han, L.; Wang, Y.; Gao, S.; Yuan, Y. Macrophage-Cancer Hybrid Membrane-Coated Nanoparticles for Targeting Lung Metastasis in Breast Cancer Therapy. J. Nanobiotechnol. 2020, 18, 1–17. DOI: 10.1186/s12951-020-00649-8.
  • Liu, Y.; Sukumar, U. K.; Kanada, M.; Krishnan, A.; Massoud, T. F.; Paulmurugan, R. Camouflaged Hybrid Cancer Cell‐Platelet Fusion Membrane Nanovesicles Deliver Therapeutic MicroRNAs to Presensitize Triple‐Negative Breast Cancer to Doxorubicin. Adv. Funct. Mater. 2021, 31, 2103600. DOI: 10.1002/adfm.202103600.
  • Bu, L.; Rao, L.; Yu, G.; Chen, L.; Deng, W.; Liu, J.; Wu, H.; Meng, Q.; Guo, S.; Zhao, X.; et al. Cancer Stem Cell‐Platelet Hybrid Membrane‐Coated Magnetic Nanoparticles for Enhanced Photothermal Therapy of Head and Neck Squamous Cell Carcinoma. Adv. Funct. Mater. 2019, 29, 1807733. DOI: 10.1002/adfm.201807733.
  • Rao, L.; Zhao, S.; Wen, C.; Tian, R.; Lin, L.; Cai, B.; Sun, Y.; Kang, F.; Yang, Z.; He, L.; et al. Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles. Adv. Mater. 2020, 32, 2004853. DOI: 10.1002/adma.202004853.
  • Ren, D.; Williams, G. R.; Zhang, Y.; Ren, R.; Lou, J.; Zhu, L.-M. Mesoporous Doxorubicin-Loaded Polydopamine Nanoparticles Coated with a Platelet Membrane Suppress Tumor Growth in a Murine Model of Human Breast Cancer. ACS Appl. Bio Mater. 2021, 5, 123–133. DOI: 10.1021/acsabm.1c00926.
  • Ding, C.; Zhang, C.; Cheng, S.; Xian, Y. Multivalent Aptamer Functionalized Ag2S Nanodots/Hybrid Cell Membrane‐Coated Magnetic Nanobioprobe for the Ultrasensitive Isolation and Detection of Circulating Tumor Cells. Adv. Funct. Mater. 2020, 30, 1909781. DOI: 10.1002/adfm.201909781.
  • Poilil Surendran, S.; Moon, M. J.; Park, R.; Jeong, Y. Y. Bioactive Nanoparticles for Cancer Immunotherapy. IJMS. 2018, 19, 3877. DOI: 10.3390/ijms19123877.
  • Zhang, M.; Du, Y.; Wang, S.; Chen, B. A Review of Biomimetic Nanoparticle Drug Delivery Systems Based on Cell Membranes. Drug Des. Devel. Ther. 2020, 14, 5495–5503. DOI: 10.2147/DDDT.S282368.
  • Mir, M.; Ahmed, N.; Ur Rehman, A. Recent Applications of PLGA Based Nanostructures in Drug Delivery. Colloids Surf. B Biointerfaces. 2017, 159, 217–231. DOI: 10.1016/j.colsurfb.2017.07.038.
  • Bhattacharyya, S.; Kudgus, R. A.; Bhattacharya, R.; Mukherjee, P. Inorganic Nanoparticles in Cancer Therapy. Pharm. Res. 2011, 28, 237–259. DOI: 10.1007/s11095-010-0318-0.
  • Tan, M. C.; Chow, G. M.; Ren, L.; Zhang, Q. Inorganic Nanoparticles for Biomedical Applications. In NanoScience in Biomedicine, Springer: Berlin, Heidelberg, 2009; pp 272–289.
  • Rodriguez, P. L.; Harada, T.; Christian, D. A.; Pantano, D. A.; Tsai, R. K.; Discher, D. E. Minimal" Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles. Sci. 2013, 339, 971–975. DOI: 10.1126/science.1229568.
  • Fan, Z.; Li, P. Y.; Deng, J.; Bady, S. C.; Cheng, H. Cell Membrane Coating for Reducing Nanoparticle-Induced Inflammatory Responses to Scaffold Constructs. Nano Res. 2018, 11, 5573–5583. DOI: 10.1007/s12274-018-2084-y.
  • Hu, C.-M. J.; Fang, R. H.; Luk, B. T.; Chen, K. N.; Carpenter, C.; Gao, W.; Zhang, K.; Zhang, L. Marker-of-Self-functionalization of Nanoscale Particles through a Top-down Cellular Membrane Coating Approach. Nanoscale. 2013, 5, 2664–2668. DOI: 10.1039/C3NR00015J.
  • Xia, Q.; Zhang, Y.; Li, Z.; Hou, X.; Feng, N. Red Blood Cell Membrane-Camouflaged Nanoparticles: A Novel Drug Delivery System for Antitumor Application. Acta Pharm. Sin. B. 2019, 9, 675–689. DOI: 10.1016/j.apsb.2019.01.011.
  • Alarifi, I. M. Membrane-Derived Nanomaterials. In Synthetic Engineering Materials and Nanotechnology, Elsevier: Amsterdam, Netherlands, 2021; pp 277–301.
  • Zeng, Y.; Li, S.; Zhang, S.; Wang, L.; Yuan, H.; Hu, F. Cell Membrane Coated-Nanoparticles for Cancer Immunotherapy. Acta Pharm. Sin. B. 2022, 12, 3233–3254. DOI: 10.1016/j.apsb.2022.02.023.
  • Bang, K.-H.; Na, Y.-G.; Huh, H. W.; Hwang, S.-J.; Kim, M.-S.; Kim, M.; Lee, H.-K.; Cho, C.-W. The Delivery Strategy of Paclitaxel Nanostructured Lipid Carrier Coated with Platelet Membrane. Cancers. 2019, 11, 807. DOI: 10.3390/cancers11060807.
  • Rao, L.; Cai, B.; Bu, L.-L.; Liao, Q.-Q.; Guo, S.-S.; Zhao, X.-Z.; Dong, W.-F.; Liu, W. Microfluidic Electroporation-Facilitated Synthesis of Erythrocyte Membrane-Coated Magnetic Nanoparticles for Enhanced Imaging-Guided Cancer Therapy. ACS Nano. 2017, 11, 3496–3505. DOI: 10.1021/acsnano.7b00133.
  • Lang, R.; Xianjia, W. Bionic Immune Magnetic Nanoparticle, Preparation Method and Application Thereof CN114487391A. 2022.
  • Zhang, J.; Gao, W.; Fang, R. H.; Dong, A.; Zhang, L. Synthesis of Nanogels via Cell Membrane‐Templated Polymerization. Small. 2015, 11, 4309–4313. DOI: 10.1002/smll.201500987.
  • Cheng, Y.; Chen, Q.; Guo, Z.; Li, M.; Yang, X.; Wan, G.; Chen, H.; Zhang, Q.; Wang, Y. An Intelligent Biomimetic Nanoplatform for Holistic Treatment of Metastatic Triple-Negative Breast Cancer via Photothermal Ablation and Immune Remodeling. ACS Nano. 2020, 14, 15161–15181. DOI: 10.1021/acsnano.0c05392.
  • Liu, H. J.; Wang, J.; Wang, M.; Wang, Y.; Shi, S.; Hu, X.; Zhang, Q.; Fan, D.; Xu, P. Biomimetic Nanomedicine Coupled with Neoadjuvant Chemotherapy to Suppress Breast Cancer Metastasis via Tumor Microenvironment Remodeling. Adv. Funct. Mater. 2021, 31, 2100262. DOI: 10.1002/adfm.202100262.
  • Fang, H.; Gai, Y.; Wang, S.; Liu, Q.; Zhang, X.; Ye, M.; Tan, J.; Long, Y.; Wang, K.; Zhang, Y.; Lan, X. Biomimetic Oxygen Delivery Nanoparticles for Enhancing Photodynamic Therapy in Triple-Negative Breast Cancer. J. Nanobiotechnol. 2021, 19, 1–14. DOI: 10.1186/s12951-021-00827-2.
  • Subbaiya, R.; Saravanan, M.; Priya, A. R.; Shankar, K. R.; Selvam, M.; Ovais, M.; Balajee, R.; Barabadi, H. Biomimetic Synthesis of Silver Nanoparticles from Streptomyces atrovirens and Their Potential Anticancer Activity against Human Breast Cancer Cells. IET Nanobiotechnol. 2017, 11, 965–972. DOI: 10.1049/iet-nbt.2016.0222.
  • Sun, K.; Yu, W.; Ji, B.; Chen, C.; Yang, H.; Du, Y.; Song, M.; Cai, H.; Yan, F.; Su, R. Saikosaponin D Loaded Macrophage Membrane-Biomimetic Nanoparticles Target Angiogenic Signaling for Breast Cancer Therapy. Appl. Mater. Today. 2020, 18, 100505. DOI: 10.1016/j.apmt.2019.100505.
  • Gong, C.; Yu, X.; Zhang, W.; Han, L.; Wang, R.; Wang, Y.; Gao, S.; Yuan, Y. Regulating the Immunosuppressive Tumor Microenvironment to Enhance Breast Cancer Immunotherapy Using pH-Responsive Hybrid Membrane-Coated Nanoparticles. J. Nanobiotechnol. 2021, 19, 1–20. DOI: 10.1186/s12951-021-00805-8.
  • Fang, H.; Li, M.; Liu, Q.; Gai, Y.; Yuan, L.; Wang, S.; Zhang, X.; Ye, M.; Zhang, Y.; Gao, M.; et al. Ultra-Sensitive Nanoprobe Modified with Tumor Cell Membrane for UCL/MRI/PET Multimodality Precise Imaging of Triple-Negative Breast Cancer. Nano-Micro. Lett. 2020, 12, 1–14. DOI: 10.1007/s40820-020-0396-4.
  • Jin, F.; Qi, J.; Liu, D.; You, Y.; Shu, G.; Du, Y.; Wang, J.; Xu, X.; Ying, X.; Ji, J.; Du, Y. Cancer-Cell-Biomimetic Upconversion Nanoparticles Combining Chemo-Photodynamic Therapy and CD73 Blockade for Metastatic Triple-Negative Breast Cancer. J. Control. Release. 2021, 337, 90–104. DOI: 10.1016/j.jconrel.2021.07.021.
  • Guo, K.; Liu, Y.; Tang, L.; Shubhra, Q. T. Homotypic Biomimetic Coating Synergizes Chemo-Photothermal Combination Therapy to Treat Breast Cancer Overcoming Drug Resistance. Chem. Eng. J. 2022, 428, 131120. DOI: 10.1016/j.cej.2021.131120.
  • Pei, W.; Huang, B.; Chen, S.; Wang, L.; Xu, Y.; Niu, C. Platelet-Mimicking Drug Delivery Nanoparticles for Enhanced Chemo-Photothermal Therapy of Breast Cancer. Int. J. Nanomed. 2020, 15, 10151–10167. DOI: 10.2147/IJN.S285952.
  • Liu, B.; Wang, W.; Fan, J.; Long, Y.; Xiao, F.; Daniyal, M.; Tong, C.; Xie, Q.; Jian, Y.; Li, B.; et al. RBC Membrane Camouflaged Prussian Blue Nanoparticles for Gamabutolin Loading and Combined Chemo/Photothermal Therapy of Breast Cancer. Biomater. 2019, 217, 119301. DOI: 10.1016/j.biomaterials.2019.119301.
  • Tian, W.; Lu, J.; Jiao, D. Stem Cell Membrane Vesicle–Coated Nanoparticles for Efficient Tumor‐Targeted Therapy of Orthotopic Breast Cancer. Polym. Adv. Technol. 2019, 30, 1051–1060. DOI: 10.1002/pat.4538.
  • Wang, X.; Zhu, X.; Li, B.; Wei, X.; Chen, Y.; Zhang, Y.; Wang, Y.; Zhang, W.; Liu, S.; Liu, Z.; et al. Intelligent Biomimetic Nanoplatform for Systemic Treatment of Metastatic Triple-Negative Breast Cancer via Enhanced EGFR-Targeted Therapy and Immunotherapy. ACS Appl. Mater. Interfaces. 2022, 14, 23152–23163. DOI: 10.1021/acsami.2c02925.
  • Rao, L.; Bu, L.-L.; Ma, L.; Wang, W.; Liu, H.; Wan, D.; Liu, J.-F.; Li, A.; Guo, S.-S.; Zhang, L.; et al. Platelet‐Facilitated Photothermal Therapy of Head and Neck Squamous Cell Carcinoma. Angew. Chem. 2018, 130, 998–1003. DOI: 10.1002/ange.201709457.
  • Kumar, P.; Van Treuren, T.; Ranjan, A. P.; Chaudhary, P.; Vishwanatha, J. K. In Vivo Imaging and Biodistribution of near Infrared Dye Loaded Brain-Metastatic-Breast-Cancer-Cell-Membrane Coated Polymeric Nanoparticles. Nanotechnol. 2019, 30, 265101. DOI: 10.1088/1361-6528/ab0f46.
  • Zhuang, J.; Gong, H.; Zhou, J.; Zhang, Q.; Gao, W.; Fang, R. H.; Zhang, L. Targeted Gene Silencing in Vivo by Platelet Membrane–Coated Metal-Organic Framework Nanoparticles. Sci. Adv. 2020, 6, eaaz6108. DOI: 10.1126/sciadv.aaz6108.
  • Cao, Y.; Yang, Y.; Feng, S.; Wan, Y. Biomimetic Cancer Cell-Coated Albumin Nanoparticles for Enhanced Colloidal Stability and Homotypic Targeting of Breast Cancer Cells. J. Drug Deliv. 2022, 75, 103698. DOI: 10.1016/j.jddst.2022.103698.
  • Meng, Q.-F.; Rao, L.; Zan, M.; Chen, M.; Yu, G.-T.; Wei, X.; Wu, Z.; Sun, Y.; Guo, S.-S.; Zhao, X.-Z.; et al. Macrophage Membrane-Coated Iron Oxide Nanoparticles for Enhanced Photothermal Tumor Therapy. Nanotechnol. 2018, 29, 134004. DOI: 10.1088/1361-6528/aaa7c7.
  • Marshall, S. K.; Angsantikul, P.; Pang, Z.; Nasongkla, N.; Hussen, R. S. D.; Thamphiwatana, S. D. Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment. Molecules. 2022, 27, 6473. DOI: 10.3390/molecules27196473.
  • Rao, L.; Bu, L.-L.; Cai, B.; Xu, J.-H.; Li, A.; Zhang, W.-F.; Sun, Z.-J.; Guo, S.-S.; Liu, W.; Wang, T.-H.; Zhao, X.-Z. Cancer Cell Membrane‐Coated Upconversion Nanoprobes for Highly Specific Tumor Imaging. Adv. Mater. 2016, 28, 3460–3466. DOI: 10.1002/adma.201506086.
  • Ma, X.; Kuang, L.; Yin, Y.; Tang, L.; Zhang, Y.; Fan, Q.; Wang, B.; Dong, Z.; Wang, W.; Yin, T.; Wang, Y. Tumor–Antigen Activated Dendritic Cell Membrane-Coated Biomimetic Nanoparticles with Orchestrating Immune Responses Promote Therapeutic Efficacy against Glioma. ACS Nano. 2023, 17, 2341–2355. DOI: 10.1016/j.bioactmat.2022.10.025.
  • Wu, H.; Du, X.; Xu, J.; Kong, X.; Li, Y.; Liu, D.; Yang, X.; Ye, L.; Ji, J.; Xi, Y.; Zhai, G. Multifunctional Biomimetic Nanoplatform Based on Photodynamic Therapy and DNA Repair Intervention for the Synergistic Treatment of Breast Cancer. Acta Biomater. 2023, 157, 551–565. DOI: 10.1016/j.actbio.2022.12.010.
  • Zhu, H.; Liu, Y.; Yi, X.; Zhu, C.; Fu, Y.; Huang, Z.; Zhu, K.; Zhang, W.; Hou, H.; Sun, C.; et al. Novel Biomimetic Mesoporous Silica Nanoparticle System Possessing Targetability and Immune Synergy Facilitates Effective Solid Tumor Immuno-Chemotherapy. Biomater. Adv. 2023, 144, 213229. DOI: 10.1016/j.bioadv.2022.213229.
  • Hu, C.-M. J.; Fang, R. H.; Wang, K.-C.; Luk, B. T.; Thamphiwatana, S.; Dehaini, D.; Nguyen, P.; Angsantikul, P.; Wen, C. H.; Kroll, A. V.; et al. Nanoparticle Biointerfacing by Platelet Membrane Cloaking. Nature. 2015, 526, 118–121. DOI: 10.1038/nature15373.
  • Kunde, S. S.; Wairkar, S. Platelet Membrane Camouflaged Nanoparticles: Biomimetic Architecture for Targeted Therapy. Int. J. Pharm. 2021, 598, 120395. DOI: 10.1016/j.ijpharm.2021.120395.
  • Zhai, Y.; Su, J.; Ran, W.; Zhang, P.; Yin, Q.; Zhang, Z.; Yu, H.; Li, Y. Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy. Theranostics. 2017, 7, 2575–2592. DOI: 10.7150/thno.20118.
  • Liu, L.; Bai, X.; Martikainen, M.-V.; Kårlund, A.; Roponen, M.; Xu, W.; Hu, G.; Tasciotti, E.; Lehto, V.-P. Cell Membrane Coating Integrity Affects the Internalization Mechanism of Biomimetic Nanoparticles. Nat. Commun. 2021, 12, 5726. DOI: 10.1038/s41467-021-26052-x.
  • Gao, W.; Hu, C. M. J.; Fang, R. H.; Luk, B. T.; Su, J.; Zhang, L. Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes. Adv. Mater. 2013, 25, 3549–3553. DOI: 10.1002/adma.201300638.
  • Tang, X.; Loc, W. S.; Dong, C.; Matters, G. L.; Butler, P. J.; Kester, M.; Meyers, C.; Jiang, Y.; Adair, J. H. The Use of Nanoparticulates to Treat Breast Cancer. Nanomed. (Lond). 2017, 12, 2367–2388. DOI: 10.2217/nnm-2017-0202.
  • Arshad, R.; Kiani, M. H.; Rahdar, A.; Sargazi, S.; Barani, M.; Shojaei, S.; Bilal, M.; Kumar, D.; Pandey, S. Nano-Based Theranostic Platforms for Breast Cancer: A Review of Latest Advancements. Bioeng. 2022, 9, 320. DOI: 10.3390/bioengineering9070320.
  • Dehaini, D.; Fang, R. H.; Zhang, L. Biomimetic Strategies for Targeted Nanoparticle Delivery. Bioeng. Transl. Med. 2016, 1, 30–46. DOI: 10.1002/btm2.10004.
  • Raza, F.; Zafar, H.; Zhang, S.; Kamal, Z.; Su, J.; Yuan, W. E.; Mingfeng, Q. Recent Advances in Cell Membrane‐Derived Biomimetic Nanotechnology for Cancer Immunotherapy. Adv. Healthcare Mater. 2021, 10, 2002081. DOI: 10.1002/adhm.202002081.
  • Kroll, A. V.; Jiang, Y.; Zhou, J.; Holay, M.; Fang, R. H.; Zhang, L. Biomimetic Nanoparticle Vaccines for Cancer Therapy. Adv. Biosys. 2019, 3, 1800219. DOI: 10.1002/adbi.201800219.
  • Zhang, T.; Liu, H.; Li, L.; Guo, Z.; Song, J.; Yang, X.; Wan, G.; Li, R.; Wang, Y. Leukocyte/Platelet Hybrid Membrane-Camouflaged Dendritic Large Pore Mesoporous Silica Nanoparticles co-Loaded with Photo/Chemotherapeutic Agents for Triple Negative Breast Cancer Combination Treatment. Bioact. Mater. 2021, 6, 3865–3878. DOI: 10.1016/j.bioactmat.2021.04.004.
  • Zhen Gu, Q. u,an,yin HU Platelet membrane-coated drug delivery system. US20180235894A1, 2019.
  • Sun Jin He Zhonggui, Y. H. W. K. Adriamycin-Indocyanine Green Bionic Nano-Particles and Application Thereof. CN111000822B, 2021.09.03, 2021.
  • Huang Jingbin, Z. R.; Wenjing, L.; Qing, W.; Qin, T.; Changpeng, H.; Guobing, L.; Min, Z.; Fengling, W.; Qian, Z.; Wuyi, L.; Dandan, X. Biological Camouflage Nano Drug Delivery System for Targeting Tumors and Preparation Method Thereof. CN112402626A, 2021.
  • Jiyuan, G. C. A Fusion Cancer Cell Membrane Imitation Based on Mesenchymal Stem Cells. CN 112516109 A, 2021.
  • Huabing, C.; Hong, Y.; Ming, L.; Cohunter, Yanhua, Z.; Yuan, W.; Xuehua, L.; Yifan, Y.; Zhenduo, Z.; Lu, W. Drug-Loaded Erythrocyte Membrane Nanoparticle and Preparation Method and Application Thereof. CN115252580A, 2022.
  • Luk, B. T.; Hu, C.-M. J.; Fang, R. H.; Dehaini, D.; Carpenter, C.; Gao, W.; Zhang, L. Interfacial Interactions between Natural RBC Membranes and Synthetic Polymeric Nanoparticles. Nanoscale. 2014, 6, 2730–2737. DOI: 10.1039/C3NR06371B.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.